行业资讯

美国开始对中国口罩企业秋后算账,首家企业面临1062万巨额罚款!

2020-06-09 02:52:16

对中国口罩企业进行的第一波清算,美国已经开始动手了!


6月5日,美国司法部发布公告,正式起诉第一家中国口罩企业-King Year Packaging and Printing Co. Ltd.(金年包装印刷有限公司)。


美国司法部给出的起诉理由是,在美国疫情期间,这家中国口罩企业生产并向美国出口将近50万个假冒伪劣的N95口罩。


美国开始对中国口罩企业秋后算账,首家企业面临1062万巨额罚款!(图1)

▲美国司法部公告


根据美国司法部的公告,这家中国口罩企业面临三项违反联邦食品,药物和化妆品法(FDCA)的指控,每项指控的最高罚款为50万美元,或者是犯罪所产生的总收入的两倍或总损失的两倍(以较高者为准)。


指控如果成立,这家企业将面临共计至少150万美元(约合1062万人民币)的巨额罚款!


美国开始对中国口罩企业秋后算账,首家企业面临1062万巨额罚款!(图2)


美国起诉书显示:


从2020年4月6日到2020年4月21日,King Year生产了495,200个假冒伪劣N95口罩,并将这些有缺陷的产品出口到美国。


为了直接吸引了医护人员和其他消费者,King Year在其呼吸器的包装上盖了NIOSH和FDA认证标识,


而实际上,这家中国口罩企业口罩未经NIOSH批准,也未经过FDA授权。虽然口罩上面印有“ N95”,实际检测出来的过滤效果远低于N95口罩最低95%的要求。


美国司法部认为这是严重的欺骗包括医护人员和急救人员在内的美国消费者的行为。并使他们处于危险之中。而为了掩盖其呼吸器质量低下的问题,King Year还对外散布了证明其真实性的虚假文件,并向FDA提交了欺诈性注册声明。


美国开始对中国口罩企业秋后算账,首家企业面临1062万巨额罚款!(图3)

▲CDC检测结果显示这家企业过滤值达不到95%这一标准


美国疾病预防与控制中心(CDC)公布的检测结果显示,这家中国口罩企业-King Year Packaging and Printing Co. Ltd.(金年包装印刷有限公司)的根本没达到N95口罩最低95%过滤效果的技术要求。


以下是美国司法部起诉公告原文:


Chinese Manufacturer Charged with Exporting Misbranded and Defective Masks Falsely Purporting to be N95 Respirators


NEWARK, N.J. – A Chinese manufacturer was charged today with producing and exporting to the United States in the midst of the COVID-19 pandemic nearly half a million misbranded and defective masks that falsely purported to be N95 respirators, U.S. Attorneys Craig Carpenito, District of New Jersey, and Richard P. Donoghue, Eastern District of New York, announced.

King Year Packaging and Printing Co. Ltd. (King Year) is charged by complaint with three counts of violating the Federal Food, Drug and Cosmetic Act (FDCA) for causing misbranded and substandard respirators that falsely purported to meet the N95 standard to be imported into the United States. The complaint also charges the defendant with one felony count of making a false statement by filing misleading registration documents with the U.S. Food and Drug Administration (FDA). The criminal complaint was filed in Brooklyn federal court.

“These charges demonstrate the continued commitment of the Department of Justice and our partners to aggressively pursue those who sell misbranded and defective personal protective equipment, whether they are located here or abroad,” Carpenito said. “We will aggressively investigate and charge manufacturers that put our medical professionals and first responders at risk in fighting this crisis.”

“The charges alleged in this complaint show a blatant disregard for the safety of American citizens,” Acting FBI-Newark Special Agent in Charge Douglas Korneski said. “Had it not been for the actions of the investigative team, this defendant would have put first responders, hospital employees, and other front line workers directly in harm’s way with faulty equipment just to make a buck. The defendant tried to bypass the government's regulations by misbranding the quality of the equipment being peddled. The FBI remains vigilant in the pursuit of criminals trying to exploit the current crisis.”

Attorney General William P. Barr created the COVID-19 Hoarding and Price Gouging Task Force, led by U.S. Attorney Carpenito, who is coordinating efforts with the Antitrust Division and U.S. Attorneys across the country wherever illegal activity involving protective personal equipment occurs. The Secretary of Health and Human Services has issued a notice designating categories of health and medical supplies that must not be hoarded or sold for exorbitant prices.

“U.S. Customs and Border Protection is proud of the expertise we bring to support and assist investigations by our law enforcement partners,” Troy Miller, Director, CBP New York Field Office, said.  “It is through interagency partnerships and collaborative efforts, like the one leading to today’s charges that we send a message to foreign manufacturers on the importance of understanding and complying with US health, safety, and import laws.”

“The FDA is actively monitoring the marketplace for fraudulent products related to our battle against COVID-19. The agency will continue to collaborate with our fellow law enforcement partners to bring to justice those who place profits above the public health during this pandemic,” Jeffrey J. Ebersole, Special Agent in Charge, FDA Office of Criminal Investigations’ New York Field Office, said. “Today’s announcement should serve as a reminder that we will take appropriate action against those who jeopardize the health of Americans while taking advantage of a crisis.”

According to the complaint:

From April 6, 2020, to April 21, 2020, King Year manufactured 495,200 defective and misbranded masks that claimed to be N95 respirators, and caused those defective products to be imported into the United States. King Year stamped the NIOSH and FDA logos on the packaging for its respirators, appealing directly to healthcare personnel, when in fact, its respirators were not NIOSH-approved, nor were they approved, cleared, or otherwise authorized by the FDA. King Year’s respirators also were embroidered with “N95,” even though they fell well below the minimum 95 percent filtration standard.

King Year’s misbranded and defective products had the potential to deceive U.S. consumers, including healthcare workers and first responders, into believing they were purchasing authentic N95 respirators, and put them at risk. To cover up the poor quality of its respirators, King Year disseminated false documents attesting to their authenticity and filed a fraudulent registration statement with the FDA.

Each charge carries a maximum fine of $500,000 or the greater of twice the gross gain or twice the gross loss from the offense.

Please report COVID-19 fraud, hoarding or price-gouging to the National Center for Disaster Fraud’s National Hotline at (866) 720-5721, or e-mail: disaster@leo.gov.

The government is represented by Assistant United States Attorney Jonathan Fayer of the Economic Crimes Unit for the U.S. Attorney’s Office for the District of New Jersey.

The charges in the complaint are merely allegations, and the defendant is presumed innocent unless and until proven guilty.


公告链接

https://www.justice.gov/usao-nj/pr/chinese-manufacturer-charged-exporting-misbranded-and-defective-masks-falsely-purporting


50万个不合格N95面临被罚1062万人民币,这家名为King Year Packaging and Printing Co. Ltd.(金年包装印刷有限公司)的中国口罩企业,是第一个撞上只是美国清算枪口的倒霉蛋,代表着美国清算行动正式开始。


美国开始对中国口罩企业秋后算账,首家企业面临1062万巨额罚款!(图4)


根据美国对于N95口罩的技术要求,在之前美国疾病预防与控制中心(CDC)官方公布的名单中,最低过滤效果低于95%的中国口罩企业竟然高达七成,这些企业接下来估计要提心吊胆了。


以下是美国疾病预防与控制中心(CDC)公布过滤值达不到95%的口罩企业名单:


美国开始对中国口罩企业秋后算账,首家企业面临1062万巨额罚款!(图5)
美国开始对中国口罩企业秋后算账,首家企业面临1062万巨额罚款!(图6)
美国开始对中国口罩企业秋后算账,首家企业面临1062万巨额罚款!(图7)
美国开始对中国口罩企业秋后算账,首家企业面临1062万巨额罚款!(图8)
美国开始对中国口罩企业秋后算账,首家企业面临1062万巨额罚款!(图9)
美国开始对中国口罩企业秋后算账,首家企业面临1062万巨额罚款!(图10)
美国开始对中国口罩企业秋后算账,首家企业面临1062万巨额罚款!(图11)

检测名单链接:https://www.cdc.gov/niosh/npptl/respirators/testing/NonNIOSHresults.html


美国法律的秋后算账和官司诉讼,不仅仅是让你吃了的吐出来,倾家荡产也是分分钟的事。


而且,如果口罩生产厂家无法找到,或者口罩标注的生产企业不承认,那么,卖家,外贸出口甚至双清包税的物流企业,都有可能陪上身家性命!



来源:搜航网